CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed
Drug / intervention
Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol) +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00403858
NCT00403858Phase 2Completed
CompareCT.gov

A Single Centre Study to Assess the Safety and Efficacy of Movicol in the Treatment of Faecal Impaction in Children Followed by a Double Blind, Randomised Phase to Compare the Safety and Efficacy of Movicol and Lactulose for Maintenance Therapy

Norgine·interventional·Posted Nov 27, 2006·Updated Jan 4, 2007

In Brief

A Phase 2 clinical trial evaluating Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol) and Lactulose for Feces, Impacted. Completed, across 1 site.

Detailed Summary

This was a single centre study comprised of two stages (Parts I and II). Part I was a 9-day open label evaluation of Movicol administered to patients in hospital. This study evaluated the safety and efficacy of Movicol in treating faecal impaction. Movicol was administered over 3 - 7 days to achieve disimpaction.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsFeces, Impacted
CountriesUnited Kingdom
Collaborators--

Timeline

Phase 2CompletedFinished
200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedNov 27, 2006
Enrollment StartOct 1, 2000
Study CompletionApr 1, 2002
TodayJul 2, 2026
Posted 19.6 years ago

Interventions

Polyethylene glycol 3350 NA bicarbonate NaCl KCl (Movicol)drug

Lactulosedrug